Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3B P/E 10.96 EPS this Y -166.70% Ern Qtrly Grth -
Income -119.03M Forward P/E 31.45 EPS next Y 350.00% 50D Avg Chg -7.00%
Sales 288.94M PEG 5.34 EPS past 5Y -57.25% 200D Avg Chg -15.00%
Dividend N/A Price/Book 3.02 EPS next 5Y -76.72% 52W High Chg -57.00%
Recommedations 1.80 Quick Ratio 7.21 Shares Outstanding 132.66M 52W Low Chg 11.00%
Insider Own 2.35% ROA -0.81% Shares Float 98.53M Beta 0.01
Inst Own 102.25% ROE -16.33% Shares Shorted/Prior 6.34M/7.35M Price 11.95
Gross Margin 48.52% Profit Margin -41.19% Avg. Volume 2,999,532 Target Price 9.88
Oper. Margin -9.09% Earnings Date May 8 Volume 6,578,673 Change 8.34%
About Maravai LifeSciences Holdings,

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Maravai LifeSciences Holdings, News
04/30/24 TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
04/18/24 TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
04/10/24 Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
03/19/24 Should You Sell Maravai LifeSciences (MRVI)?
03/12/24 Maravai LifeSciences Announces March 2024 Investor Conference Schedule
02/24/24 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating Their Estimates
02/23/24 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript
02/23/24 Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call
02/22/24 Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript
02/22/24 Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance
02/22/24 Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
02/21/24 TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
02/13/24 Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
02/11/24 3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
02/07/24 Will Maravai LifeSciences Holdings (MRVI) Pipeline Start to Bear Fruit?
02/05/24 Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
01/29/24 Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
12/18/23 Bank of America Pounds the Table on These 3 Buy-Rated Stocks
11/24/23 Are Options Traders Betting on a Big Move in Maravai LifeSciences (MRVI) Stock?
11/16/23 Analyst Forecasts Just Became More Bearish On Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
MRVI Chatroom

User Image DonCorleone77 Posted - 04/30/24

$MRVI Maravai Lifesciences subsidiary, Lonza enter license and supply pact for capping TriLink BioTechnologies, a Maravai LifeSciences company, has signed a non-exclusive license and supply agreement with Lonza. According to the terms of the agreement, TriLink will supply its patented CleanCap M6, CleanCap AG 3'OMe, CleanCap AG, and CleanCap AU cap analogs for use in Lonza's global mRNA development and manufacturing services, from pre-clinical through Phase III programs. CleanCap technology is a one-pot solution with over 95% capping efficiency that streamlines mRNA production processes when compared to legacy capping methods.

User Image Stock_Titan Posted - 04/30/24

$MRVI TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology https://www.stocktitan.net/news/MRVI/tri-link-bio-technologies-r-and-lonza-enter-into-non-exclusive-f5xm8v0yiuxr.html

User Image Stock_Titan Posted - 04/18/24

$MRVI TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production https://www.stocktitan.net/news/MRVI/tri-link-bio-technologies-r-announces-new-san-diego-facility-for-y37fkfbldm3i.html

User Image Stock_Titan Posted - 04/10/24

$MRVI Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 https://www.stocktitan.net/news/MRVI/maravai-life-sciences-to-host-earnings-conference-call-on-wednesday-bhy29yjcdniz.html

User Image DonCorleone77 Posted - 04/10/24

$MRVI Craig-Hallum bullish on Maravai Lifesciences, initiates with a Buy Craig-Hallum initiated coverage of Maravai Lifesciences with a Buy rating and $15 price target. The firm believes shares of Maravai are poised for a rebound and thinks investors should add the stock to their portfolios. FY23 was a challenging year on multiple fronts as COVID-related revenues fell off, pharma/biotech funding dried up resulting in slower drug development and a reprioritization of pipelines. The funding environment is improving, and pharma/biotech companies are moving ahead with development plans resulting in increasing demand in the gene editing, cell and gene therapy and biologic drug manufacturing end markets. Craig-Hallum believes Maravai Lifesciences provides investors with the opportunity to participate in each of these high-growth markets.

User Image ApeTownBanger Posted - 04/09/24

$MRVI

User Image DitchRider Posted - 03/28/24

$MRVI

User Image TrendsetterTrading Posted - 03/24/24

$MRVI $8.50 breakout looking solid for continuation higher ⬆️

User Image RollingDollar Posted - 03/23/24

$MRVI

User Image dojidad Posted - 03/23/24

$MRVI It's like a groundhog popping its head out and looking for his shadow. Will it be Spring and he'll emerge? Or will winter continue and he goes back underground. He's looking around as we speak......

User Image josephfuller Posted - 03/23/24

$MRVI CATX PEOPLE IT’S THE NEXT RADIONUCLIDE!.

User Image RiskVsReward Posted - 03/23/24

$MRVI Watch this as we get into key support and resistance levels here. 🚨

User Image dixiebull Posted - 03/23/24

$MRVI nice grind and testing the 200ma, I like that the 50 is curling up as well. Possible longer term hold. Day trade can take it to 10.

User Image GSP Posted - 03/20/24

I like the look of this $MRVI chart. Keep it on your radar.

User Image GSP Posted - 03/20/24

Trading Watch List Video for March 21st (con't): $TKO $NNOX $MRVI $CXAI $GOEV Watch here: https://greatstockpix.com/march-21st-day-trading-watch-list/

User Image GSP Posted - 03/19/24

$MRVI is pretty coiled here. It's on our watch list for tomorrow.

User Image TraderIsaac Posted - 03/19/24

$MRVI Looks even better now.

User Image GSP Posted - 03/19/24

Day Trading Watch List Video for March 20th: $SPY $CGC $NNOX $MRVI $CDLX Watch here: https://greatstockpix.com/march-20th-day-trading-watch-list/

User Image GSP Posted - 03/18/24

$MRVI makes our watch list for Tuesday.

User Image GSP Posted - 03/18/24

Day Trading Watch List Video for March 19th (con't): $MRVI $PIXY $LICY $LSF $CRDF Watch here: https://greatstockpix.com/march-19th-day-trading-watch-list/

User Image ApeTownBanger Posted - 03/18/24

$MRVI come on, lets get an offer for 65$ and get over with it.

User Image TraderIsaac Posted - 03/17/24

$MRVI On WL. HVE PEG. Would wait for VCP completion with 1 more higher high & low to let ⚓️VWAP curl up under price, rather than buying DTL breakout. 🤔

User Image Ahirsch1 Posted - 03/13/24

$MRVI gotta love that daily

User Image Ahirsch1 Posted - 03/13/24

$MRVI OHHH YA I CAN ALMOST TASTE $10🤝

User Image Stock_Titan Posted - 03/12/24

$MRVI Maravai LifeSciences Announces March 2024 Investor Conference Schedule https://www.stocktitan.net/news/MRVI/maravai-life-sciences-announces-march-2024-investor-conference-9fbyz8uoda0i.html

User Image Ahirsch1 Posted - 03/12/24

$MRVI $10 by Friday so I can eat cereal with milk instead of water

User Image Ahirsch1 Posted - 03/11/24

$MRVI 7% pre market got ripped away in a second😂

User Image Ahirsch1 Posted - 03/11/24

$MRVI on our way to $10😍

User Image GSP Posted - 03/10/24

Keep $MRVI on your radar this week.

User Image GSP Posted - 03/10/24

Trading Watch List Video for March 11th (con't): $MRVI $TNDM $METC $PRCH $LTRN Watch here: https://greatstockpix.com/march-11th-day-trading-watch-list/

Analyst Ratings
Craig-Hallum Buy Apr 10, 24
RBC Capital Outperform Feb 23, 24
Stifel Buy Feb 23, 24
B of A Securities Buy Dec 12, 23
Goldman Sachs Neutral Nov 9, 23
Morgan Stanley Overweight Nov 9, 23
Morgan Stanley Overweight Aug 9, 23
Deutsche Bank Buy Aug 8, 23
RBC Capital Outperform Aug 8, 23